Entrada Therapeutics
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2016-01-01
- Employees
- 159
- Market Cap
- $621.2M
- Website
- http://www.entradatx.com
Natural History Study of MNGIE
Suspended
- Conditions
- Mitochondrial Neurogastrointestinal Encephalomyopathy
- Interventions
- Other: Non-interventional
- First Posted Date
- 2020-01-29
- Last Posted Date
- 2021-07-22
- Lead Sponsor
- Entrada Therapeutics, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT04245917
- Locations
- 🇺🇸
Columbia University, New York, New York, United States
🇺🇸Baylor St Luke's Medical Center and Texas Children's Hospital at Baylor College of Medicine, Houston, Texas, United States
🇺🇸Children's Hospital Colorado, Aurora, Colorado, United States
© Copyright 2025. All Rights Reserved by MedPath